Spectrum Biomedical UK
Spectrum Biomedical UK provides access to reliable cannabis-based medicinal products to UK patients. Under the British government’s new classification, specialist physicians can prescribe cannabis-based medicines to their patients to help them manage a wide range of symptoms – from chronic pain, chemotherapy-induced nausea and vomiting, to muscle spasticity for those with multiple sclerosis.
The Company is prioritizing physician education to ensure doctors are exposed to the deep breadth of research demonstrating the therapeutic benefits of cannabis as Spectrum seeks to import cannabis products into the market. The combination of these actions helps build capacity within the UK’s healthcare sector and will provide patients reliable access to Spectrum Cannabis products and information physicians can use to support them in their practice.